Innovative Technologies Impacted by COVID–19 Act

Innovative Technologies Impacted by COVID-19 Act

This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9559 Introduced in House (IH)]

<DOC>






117th CONGRESS
  2d Session
                                H. R. 9559

  To amend title XVIII of the Social Security Act to extend the pass-
                  through period for certain devices.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           December 14, 2022

 Mr. Schneider (for himself, Mr. LaHood, Mr. Perlmutter, Mr. Dunn, and 
 Ms. DeGette) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
  To amend title XVIII of the Social Security Act to extend the pass-
                  through period for certain devices.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Innovative Technologies Impacted by 
COVID-19 Act''.

SEC. 2. EXTENDING PASS-THROUGH STATUS UNDER THE MEDICARE PROGRAM FOR 
              CERTAIN DEVICES.

    Section 1833(t)(6) of the Social Security Act (42 U.S.C. 
1395l(t)(6)) is amended by adding at the end the following new 
subparagraph:
                    ``(K) Pass-through extension for certain devices.--
                In the case of a device with respect to which the pass-
                through status under this paragraph would, but for 
                application of this subparagraph, end on December 31, 
                2022, such pass-through status shall be extended for 
                the 1-year period beginning on January 1, 2023.''.
                                 <all>